"Êxtase": revisão farmacológica
Maristela Ferigolo, Fernanda Borges de Medeiros, Helena Maria Tannhauser Barros
Revista de Saúde Pública October 1, 1998 DOI: 10.1590/s0034-89101998000500014 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 7 |
| Key findings | The review describes MDMA's trajectory from synthesis to psychotherapeutic adjunct to drug of abuse, and argues that pharmacokinetic and mechanistic findings help explain its toxic psychiatric and physical side effects, its self-administration, and a possible treatment for intoxication. It reviews international abuse patterns to anticipate trends in Brazil, where abuse reports have already appeared. |
Abstract
A literature review on 3,4 methylenedioxymethanphetaneine (MDMA), known as ecstasy, a drug with increased use among youngsters is presented. The history from its synthesis, up to its use as an adjunct to psychotherapy and, more recently, as a drug of abuse, is described. The possible pattern of abuse in several countries is reviewed with the objective of predicting what might happen in Brazil, where some reports of abuse have already appeared. The pharmacokinetics of MDMA is also reviewed to explain the consequences for pharmacological activity, toxicology and adverse effects. The clinical outcome of both short and middle-term intoxication is summarized and the clinical symptoms of severe intoxication with ecstasy, are described. The studies undertaken on its mechanism of action are detailed to explain its toxic psychiatric and physical side effects, to explain the mechanism of self-administration of the drug and to propose a therapeutic possibility of treating intoxication.
Citations in the library
Cites 23
- Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens Journal of Psychoactive Drugs October 1, 1986
- Subjective Reports of the Effects of MDMA in a Clinical Setting Journal of Psychoactive Drugs October 1, 1986
- 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA JAMA March 27, 1987
- 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans Addiction May 1, 1994
- (±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates JAMA July 1, 1988
and 18 more in the library